RATIONALE: Surfactant protein D (SP-D) is a collectin family member with demonstrated immunomodulatory properties in vitro. We hypothesized that SP-D modulates inflammation during noninfectious lung injury in vivo. OBJECTIVES: To investigate the association of alveolar SP-D and injury, we studied the responses of transgenic mice expressing varying levels of SP-D to intratracheal bleomycin (ITB). METHODS: Eight-week old C57/BL6 SP-D-deficient (-/-) mice and syngeneic wild-type (WT) controls or Swiss Black SP-D-overexpressing (SP-D OE) mice and littermate controls received either ITB or saline and were followed for up to 21 d. MEASUREMENTS AND RESULTS: Kaplan-Meier analysis demonstrated a dose-dependent decrease in survival in ITB SP-D (-/-) mice receiving 2 U/kg bleomycin, with a 14-d mortality of 100% versus 0% mortality for WT receiving 2 U/kg ITB or SP-D (-/-) mice given saline (p < 0.05). At 8 d, ITB SP-D (-/-) mice had greater respiratory distress (frequency/tidal volume) and weight loss than ITB WT mice. Furthermore, bronchoalveolar lavage cellularity, pulmonary parenchymal inflammation, and tissue 3-nitrotyrosine (NO2 Y) were increased to a greater extent in ITB SP-D (-/-) mice. By 21 d, compared with all groups, ITB SP-D (-/-) survivors had increased Trichrome staining and tissue hydroxyproline levels. As proof of principle, SP-D OE mice were highly resistant to bleomycin-induced morbidity and mortality at doses up to 3 U/kg. CONCLUSIONS: These data provide new in vivo evidence for an antiinflammatory role for SP-D in response to noninfectious, subacute lung injury via modulation of oxidative-nitrative stress.
RATIONALE: Surfactant protein D (SP-D) is a collectin family member with demonstrated immunomodulatory properties in vitro. We hypothesized that SP-D modulates inflammation during noninfectious lung injury in vivo. OBJECTIVES: To investigate the association of alveolar SP-D and injury, we studied the responses of transgenic mice expressing varying levels of SP-D to intratracheal bleomycin (ITB). METHODS: Eight-week old C57/BL6 SP-D-deficient (-/-) mice and syngeneic wild-type (WT) controls or Swiss Black SP-D-overexpressing (SP-D OE) mice and littermate controls received either ITB or saline and were followed for up to 21 d. MEASUREMENTS AND RESULTS: Kaplan-Meier analysis demonstrated a dose-dependent decrease in survival in ITBSP-D (-/-) mice receiving 2 U/kg bleomycin, with a 14-d mortality of 100% versus 0% mortality for WT receiving 2 U/kg ITB or SP-D (-/-) mice given saline (p < 0.05). At 8 d, ITBSP-D (-/-) mice had greater respiratory distress (frequency/tidal volume) and weight loss than ITB WT mice. Furthermore, bronchoalveolar lavage cellularity, pulmonary parenchymal inflammation, and tissue 3-nitrotyrosine (NO2 Y) were increased to a greater extent in ITBSP-D (-/-) mice. By 21 d, compared with all groups, ITBSP-D (-/-) survivors had increased Trichrome staining and tissue hydroxyproline levels. As proof of principle, SP-D OE mice were highly resistant to bleomycin-induced morbidity and mortality at doses up to 3 U/kg. CONCLUSIONS: These data provide new in vivo evidence for an antiinflammatory role for SP-D in response to noninfectious, subacute lung injury via modulation of oxidative-nitrative stress.
Authors: S E Wert; M Yoshida; A M LeVine; M Ikegami; T Jones; G F Ross; J H Fisher; T R Korfhagen; J A Whitsett Journal: Proc Natl Acad Sci U S A Date: 2000-05-23 Impact factor: 11.205
Authors: J H Fisher; V Sheftelyevich; Y S Ho; S Fligiel; F X McCormack; T R Korfhagen; J A Whitsett; M Ikegami Journal: Am J Physiol Lung Cell Mol Physiol Date: 2000-02 Impact factor: 5.464
Authors: R C Savani; Z Zhou; E Arguiri; S Wang; D Vu; C C Howe; H M DeLisser Journal: Am J Physiol Lung Cell Mol Physiol Date: 2000-10 Impact factor: 5.464
Authors: Maria Quisgaard Gaunsbaek; Karina Juhl Rasmussen; Michael F Beers; Elena N Atochina-Vasserman; Soren Hansen Journal: Lung Date: 2013-02-24 Impact factor: 2.584
Authors: Vasanthi R Sunil; Kinal N Vayas; Jessica A Cervelli; Elena V Ebramova; Andrew J Gow; Michael Goedken; Rama Malaviya; Jeffrey D Laskin; Debra L Laskin Journal: Toxicol Sci Date: 2018-11-01 Impact factor: 4.849
Authors: Elena N Atochina-Vasserman; Sandra R Bates; Peggy Zhang; Helen Abramova; Zhenguo Zhang; Linda Gonzales; Jian-Qin Tao; Bernadette R Gochuico; William Gahl; Chang-Jiang Guo; Andrew J Gow; Michael F Beers; Susan Guttentag Journal: Am J Respir Crit Care Med Date: 2011-08-15 Impact factor: 21.405
Authors: G J Rey-Parra; A Vadivel; L Coltan; A Hall; F Eaton; M Schuster; H Loibner; J M Penninger; Z Kassiri; G Y Oudit; B Thébaud Journal: J Mol Med (Berl) Date: 2012-01-14 Impact factor: 4.599
Authors: Kendra Gram; Shuxia Yang; Marie Steiner; Arif Somani; Samuel Hawgood; Bruce R Blazar; Angela Panoskaltsis-Mortari; Imad Y Haddad Journal: Am J Physiol Lung Cell Mol Physiol Date: 2008-11-07 Impact factor: 5.464
Authors: Lars Knudsen; Elena N Atochina-Vasserman; Christopher B Massa; Bastian Birkelbach; Chang-Jiang Guo; Pamela Scott; Beat Haenni; Michael F Beers; Matthias Ochs; Andrew J Gow Journal: Am J Physiol Lung Cell Mol Physiol Date: 2015-08-28 Impact factor: 5.464